• レポートコード:MRC23Q30441 • 出版社/出版日:QYResearch / 2023年3月 • レポート形態:英文、PDF、90ページ • 納品方法:Eメール(2-3日) • 産業分類:化学&材料 |
Single User | ¥435,000 (USD2,900) | ▷ お問い合わせ |
Enterprise License | ¥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界のサルタン系医薬品におけるAPI市場について調査・分析し、世界のサルタン系医薬品におけるAPI市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析(ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI)、用途別セグメント分析(錠剤、カプセル剤、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Dr. Reddy’s Laboratories、Verdant Pharma Pvt Ltd、Anuh Pharma Ltd.、Ningbo Menovo Pharmaceutical、Tianyu Pharmaceutical、Zhejiang Huahai Pharmaceutical、Changzhou Kony Pharmaceutical、Zhejiang Kinglyuan Pharmaceutical、Zhejiang Xinsaike Pharmaceutical、Rundu Pharmaなどが含まれています。世界のサルタン系医薬品におけるAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争による影響は、サルタン系医薬品におけるAPI市場規模を推定する際に考慮しました。本レポートは、サルタン系医薬品におけるAPIの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、サルタン系医薬品におけるAPIに関するビジネス上の意思決定に役立てることを目的としています。 ・サルタン系医薬品におけるAPI市場の概要 - 製品の定義 - サルタン系医薬品におけるAPIのタイプ別セグメント - 世界のサルタン系医薬品におけるAPI市場成長率のタイプ別分析(ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI) - サルタン系医薬品におけるAPIの用途別セグメント - 世界のサルタン系医薬品におけるAPI市場成長率の用途別分析(錠剤、カプセル剤、その他) - 世界市場の成長展望 - 世界のサルタン系医薬品におけるAPI生産量の推定と予測(2018年-2029年) - 世界のサルタン系医薬品におけるAPI生産能力の推定と予測(2018年-2029年) - サルタン系医薬品におけるAPIの平均価格の推定と予測(2018年-2029年) - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - サルタン系医薬品におけるAPI市場の競争状況およびトレンド ・サルタン系医薬品におけるAPIの地域別生産量 - サルタン系医薬品におけるAPI生産量の地域別推計と予測(2018年-2029年) - 地域別サルタン系医薬品におけるAPI価格分析(2018年-2023年) - 北米のサルタン系医薬品におけるAPI生産規模(2018年-2029年) - ヨーロッパのサルタン系医薬品におけるAPI生産規模(2018年-2029年) - 中国のサルタン系医薬品におけるAPI生産規模(2018年-2029年) - 日本のサルタン系医薬品におけるAPI生産規模(2018年-2029年) - 韓国のサルタン系医薬品におけるAPI生産規模(2018年-2029年) - インドのサルタン系医薬品におけるAPI生産規模(2018年-2029年) ・サルタン系医薬品におけるAPIの地域別消費量 - サルタン系医薬品におけるAPI消費量の地域別推計と予測(2018年-2029年) - 北米のサルタン系医薬品におけるAPI消費量(2018年-2029年) - アメリカのサルタン系医薬品におけるAPI消費量(2018年-2029年) - ヨーロッパのサルタン系医薬品におけるAPI消費量(2018年-2029年) - アジア太平洋のサルタン系医薬品におけるAPI消費量(2018年-2029年) - 中国のサルタン系医薬品におけるAPI消費量(2018年-2029年) - 日本のサルタン系医薬品におけるAPI消費量(2018年-2029年) - 韓国のサルタン系医薬品におけるAPI消費量(2018年-2029年) - 東南アジアのサルタン系医薬品におけるAPI消費量(2018年-2029年) - インドのサルタン系医薬品におけるAPI消費量(2018年-2029年) - 中南米・中東・アフリカのサルタン系医薬品におけるAPI消費量(2018年-2029年) ・タイプ別セグメント:ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI - 世界のサルタン系医薬品におけるAPIのタイプ別生産量(2018年-2023年) - 世界のサルタン系医薬品におけるAPIのタイプ別生産量(2024年-2029年) - 世界のサルタン系医薬品におけるAPIのタイプ別価格 ・用途別セグメント:錠剤、カプセル剤、その他 - 世界のサルタン系医薬品におけるAPIの用途別生産量(2018年-2023年) - 世界のサルタン系医薬品におけるAPIの用途別生産量(2024年-2029年) - 世界のサルタン系医薬品におけるAPIの用途別価格 ・主要企業のプロファイル:企業情報、製品ポートフォリオ、生産量、価格、動向 Dr. Reddy’s Laboratories、Verdant Pharma Pvt Ltd、Anuh Pharma Ltd.、Ningbo Menovo Pharmaceutical、Tianyu Pharmaceutical、Zhejiang Huahai Pharmaceutical、Changzhou Kony Pharmaceutical、Zhejiang Kinglyuan Pharmaceutical、Zhejiang Xinsaike Pharmaceutical、Rundu Pharma ・産業チェーンと販売チャネルの分析 - サルタン系医薬品におけるAPI産業チェーン分析 - サルタン系医薬品におけるAPIの主要原材料 - サルタン系医薬品におけるAPIの販売チャネル - サルタン系医薬品におけるAPIのディストリビューター - サルタン系医薬品におけるAPIの主要顧客 ・サルタン系医薬品におけるAPI市場ダイナミクス - サルタン系医薬品におけるAPIの業界動向 - サルタン系医薬品におけるAPI市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The global API of Sartan Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for API of Sartan Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for API of Sartan Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of API of Sartan Drugs include Dr. Reddy’s Laboratories, Verdant Pharma Pvt Ltd, Anuh Pharma Ltd., Ningbo Menovo Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Huahai Pharmaceutical, Changzhou Kony Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical and Zhejiang Xinsaike Pharmaceutical, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for API of Sartan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API of Sartan Drugs.
The API of Sartan Drugs market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global API of Sartan Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API of Sartan Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dr. Reddy’s Laboratories
Verdant Pharma Pvt Ltd
Anuh Pharma Ltd.
Ningbo Menovo Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Huahai Pharmaceutical
Changzhou Kony Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Zhejiang Xinsaike Pharmaceutical
Rundu Pharma
Segment by Type
Losartan API
Valsartan API
Irbesartan API
Olmesartan API
Candesartan API
Telmisartan API
Segment by Application
Tablets
Capsules
Others
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of API of Sartan Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of API of Sartan Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of API of Sartan Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 API of Sartan Drugs Market Overview
1.1 Product Definition
1.2 API of Sartan Drugs Segment by Type
1.2.1 Global API of Sartan Drugs Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Losartan API
1.2.3 Valsartan API
1.2.4 Irbesartan API
1.2.5 Olmesartan API
1.2.6 Candesartan API
1.2.7 Telmisartan API
1.3 API of Sartan Drugs Segment by Application
1.3.1 Global API of Sartan Drugs Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global API of Sartan Drugs Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global API of Sartan Drugs Production Estimates and Forecasts (2018-2029)
1.4.4 Global API of Sartan Drugs Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global API of Sartan Drugs Production Market Share by Manufacturers (2018-2023)
2.2 Global API of Sartan Drugs Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of API of Sartan Drugs, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global API of Sartan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global API of Sartan Drugs Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of API of Sartan Drugs, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of API of Sartan Drugs, Product Offered and Application
2.8 Global Key Manufacturers of API of Sartan Drugs, Date of Enter into This Industry
2.9 API of Sartan Drugs Market Competitive Situation and Trends
2.9.1 API of Sartan Drugs Market Concentration Rate
2.9.2 Global 5 and 10 Largest API of Sartan Drugs Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 API of Sartan Drugs Production by Region
3.1 Global API of Sartan Drugs Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global API of Sartan Drugs Production Value by Region (2018-2029)
3.2.1 Global API of Sartan Drugs Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of API of Sartan Drugs by Region (2024-2029)
3.3 Global API of Sartan Drugs Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global API of Sartan Drugs Production by Region (2018-2029)
3.4.1 Global API of Sartan Drugs Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of API of Sartan Drugs by Region (2024-2029)
3.5 Global API of Sartan Drugs Market Price Analysis by Region (2018-2023)
3.6 Global API of Sartan Drugs Production and Value, Year-over-Year Growth
3.6.1 North America API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
3.6.3 China API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
3.6.5 India API of Sartan Drugs Production Value Estimates and Forecasts (2018-2029)
4 API of Sartan Drugs Consumption by Region
4.1 Global API of Sartan Drugs Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global API of Sartan Drugs Consumption by Region (2018-2029)
4.2.1 Global API of Sartan Drugs Consumption by Region (2018-2023)
4.2.2 Global API of Sartan Drugs Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America API of Sartan Drugs Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America API of Sartan Drugs Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe API of Sartan Drugs Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe API of Sartan Drugs Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific API of Sartan Drugs Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific API of Sartan Drugs Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa API of Sartan Drugs Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa API of Sartan Drugs Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global API of Sartan Drugs Production by Type (2018-2029)
5.1.1 Global API of Sartan Drugs Production by Type (2018-2023)
5.1.2 Global API of Sartan Drugs Production by Type (2024-2029)
5.1.3 Global API of Sartan Drugs Production Market Share by Type (2018-2029)
5.2 Global API of Sartan Drugs Production Value by Type (2018-2029)
5.2.1 Global API of Sartan Drugs Production Value by Type (2018-2023)
5.2.2 Global API of Sartan Drugs Production Value by Type (2024-2029)
5.2.3 Global API of Sartan Drugs Production Value Market Share by Type (2018-2029)
5.3 Global API of Sartan Drugs Price by Type (2018-2029)
6 Segment by Application
6.1 Global API of Sartan Drugs Production by Application (2018-2029)
6.1.1 Global API of Sartan Drugs Production by Application (2018-2023)
6.1.2 Global API of Sartan Drugs Production by Application (2024-2029)
6.1.3 Global API of Sartan Drugs Production Market Share by Application (2018-2029)
6.2 Global API of Sartan Drugs Production Value by Application (2018-2029)
6.2.1 Global API of Sartan Drugs Production Value by Application (2018-2023)
6.2.2 Global API of Sartan Drugs Production Value by Application (2024-2029)
6.2.3 Global API of Sartan Drugs Production Value Market Share by Application (2018-2029)
6.3 Global API of Sartan Drugs Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories
7.1.1 Dr. Reddy’s Laboratories API of Sartan Drugs Corporation Information
7.1.2 Dr. Reddy’s Laboratories API of Sartan Drugs Product Portfolio
7.1.3 Dr. Reddy’s Laboratories API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dr. Reddy’s Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.2 Verdant Pharma Pvt Ltd
7.2.1 Verdant Pharma Pvt Ltd API of Sartan Drugs Corporation Information
7.2.2 Verdant Pharma Pvt Ltd API of Sartan Drugs Product Portfolio
7.2.3 Verdant Pharma Pvt Ltd API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Verdant Pharma Pvt Ltd Main Business and Markets Served
7.2.5 Verdant Pharma Pvt Ltd Recent Developments/Updates
7.3 Anuh Pharma Ltd.
7.3.1 Anuh Pharma Ltd. API of Sartan Drugs Corporation Information
7.3.2 Anuh Pharma Ltd. API of Sartan Drugs Product Portfolio
7.3.3 Anuh Pharma Ltd. API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Anuh Pharma Ltd. Main Business and Markets Served
7.3.5 Anuh Pharma Ltd. Recent Developments/Updates
7.4 Ningbo Menovo Pharmaceutical
7.4.1 Ningbo Menovo Pharmaceutical API of Sartan Drugs Corporation Information
7.4.2 Ningbo Menovo Pharmaceutical API of Sartan Drugs Product Portfolio
7.4.3 Ningbo Menovo Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Ningbo Menovo Pharmaceutical Main Business and Markets Served
7.4.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
7.5 Tianyu Pharmaceutical
7.5.1 Tianyu Pharmaceutical API of Sartan Drugs Corporation Information
7.5.2 Tianyu Pharmaceutical API of Sartan Drugs Product Portfolio
7.5.3 Tianyu Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Tianyu Pharmaceutical Main Business and Markets Served
7.5.5 Tianyu Pharmaceutical Recent Developments/Updates
7.6 Zhejiang Huahai Pharmaceutical
7.6.1 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Corporation Information
7.6.2 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Product Portfolio
7.6.3 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.6.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.7 Changzhou Kony Pharmaceutical
7.7.1 Changzhou Kony Pharmaceutical API of Sartan Drugs Corporation Information
7.7.2 Changzhou Kony Pharmaceutical API of Sartan Drugs Product Portfolio
7.7.3 Changzhou Kony Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Changzhou Kony Pharmaceutical Main Business and Markets Served
7.7.5 Changzhou Kony Pharmaceutical Recent Developments/Updates
7.8 Zhejiang Kinglyuan Pharmaceutical
7.8.1 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Corporation Information
7.8.2 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Product Portfolio
7.8.3 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Zhejiang Kinglyuan Pharmaceutical Main Business and Markets Served
7.7.5 Zhejiang Kinglyuan Pharmaceutical Recent Developments/Updates
7.9 Zhejiang Xinsaike Pharmaceutical
7.9.1 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Corporation Information
7.9.2 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Product Portfolio
7.9.3 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhejiang Xinsaike Pharmaceutical Main Business and Markets Served
7.9.5 Zhejiang Xinsaike Pharmaceutical Recent Developments/Updates
7.10 Rundu Pharma
7.10.1 Rundu Pharma API of Sartan Drugs Corporation Information
7.10.2 Rundu Pharma API of Sartan Drugs Product Portfolio
7.10.3 Rundu Pharma API of Sartan Drugs Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Rundu Pharma Main Business and Markets Served
7.10.5 Rundu Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 API of Sartan Drugs Industry Chain Analysis
8.2 API of Sartan Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 API of Sartan Drugs Production Mode & Process
8.4 API of Sartan Drugs Sales and Marketing
8.4.1 API of Sartan Drugs Sales Channels
8.4.2 API of Sartan Drugs Distributors
8.5 API of Sartan Drugs Customers
9 API of Sartan Drugs Market Dynamics
9.1 API of Sartan Drugs Industry Trends
9.2 API of Sartan Drugs Market Drivers
9.3 API of Sartan Drugs Market Challenges
9.4 API of Sartan Drugs Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer